IS2484B - Notkun á tilteknum skammti af fondaparínux-natríum til meðhöndlunar á bráðum heilkennum kransæðabilana - Google Patents

Notkun á tilteknum skammti af fondaparínux-natríum til meðhöndlunar á bráðum heilkennum kransæðabilana

Info

Publication number
IS2484B
IS2484B IS7199A IS7199A IS2484B IS 2484 B IS2484 B IS 2484B IS 7199 A IS7199 A IS 7199A IS 7199 A IS7199 A IS 7199A IS 2484 B IS2484 B IS 2484B
Authority
IS
Iceland
Prior art keywords
fondaparinx
sodium
treatment
coronary artery
acute coronary
Prior art date
Application number
IS7199A
Other languages
English (en)
Other versions
IS7199A (is
Inventor
Wilhelmus Arnold Lensing Anthonie
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2484(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of IS7199A publication Critical patent/IS7199A/is
Publication of IS2484B publication Critical patent/IS2484B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS7199A 2001-11-13 2004-03-29 Notkun á tilteknum skammti af fondaparínux-natríum til meðhöndlunar á bráðum heilkennum kransæðabilana IS2484B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204323 2001-11-13
PCT/EP2002/012482 WO2003041722A1 (en) 2001-11-13 2002-11-07 Use of specific dose of fondaparinux sodium for the treatment of acs

Publications (2)

Publication Number Publication Date
IS7199A IS7199A (is) 2004-03-29
IS2484B true IS2484B (is) 2008-12-15

Family

ID=8181220

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7199A IS2484B (is) 2001-11-13 2004-03-29 Notkun á tilteknum skammti af fondaparínux-natríum til meðhöndlunar á bráðum heilkennum kransæðabilana

Country Status (37)

Country Link
US (1) US20040248848A1 (is)
EP (1) EP1446131B1 (is)
JP (1) JP4523276B2 (is)
KR (1) KR20050044318A (is)
CN (1) CN1602197A (is)
AP (1) AP1820A (is)
AR (1) AR037291A1 (is)
AT (1) ATE361753T1 (is)
AU (1) AU2002351915B2 (is)
BR (1) BR0212915A (is)
CA (1) CA2465776A1 (is)
CO (1) CO5580790A2 (is)
CY (1) CY1106765T1 (is)
DE (1) DE60220084T2 (is)
DK (1) DK1446131T3 (is)
EA (1) EA007325B1 (is)
EC (1) ECSP045041A (is)
ES (1) ES2287343T3 (is)
GE (1) GEP20074097B (is)
HK (1) HK1070561A1 (is)
HR (1) HRP20040303B1 (is)
HU (1) HU228959B1 (is)
IL (2) IL161114A0 (is)
IS (1) IS2484B (is)
MA (1) MA27071A1 (is)
ME (2) MEP1108A (is)
MX (1) MXPA04003045A (is)
NO (1) NO20041320L (is)
NZ (1) NZ552129A (is)
PE (1) PE20030740A1 (is)
PL (1) PL206008B1 (is)
PT (1) PT1446131E (is)
RS (1) RS50906B (is)
SI (1) SI1446131T1 (is)
UA (1) UA80399C2 (is)
WO (1) WO2003041722A1 (is)
ZA (1) ZA200402464B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075910A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched fondaparinux
AU2016235662B2 (en) * 2015-03-20 2020-07-30 Aarhus Universitet Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN107595769A (zh) * 2017-10-23 2018-01-19 上海博悦生物科技有限公司 一种磺达肝癸钠注射液组合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
CA2199642C (en) * 1997-03-10 2001-05-08 Roger Cariou Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
EP1551852A4 (en) * 2002-04-25 2007-03-21 Momenta Pharmaceuticals Inc METHOD AND PRODUCTS FOR MUCOSAL DELIVERY

Also Published As

Publication number Publication date
JP4523276B2 (ja) 2010-08-11
NO20041320L (no) 2004-06-14
ME00229B (me) 2011-10-10
PT1446131E (pt) 2007-08-07
HU228959B1 (en) 2013-07-29
IS7199A (is) 2004-03-29
CN1602197A (zh) 2005-03-30
HK1070561A1 (en) 2005-06-24
MXPA04003045A (es) 2005-06-20
US20040248848A1 (en) 2004-12-09
EA200400382A1 (ru) 2004-10-28
CA2465776A1 (en) 2003-05-22
AP1820A (en) 2008-01-11
HRP20040303A2 (en) 2004-10-31
EP1446131B1 (en) 2007-05-09
HUP0401462A3 (en) 2006-04-28
RS26704A (en) 2007-02-05
ECSP045041A (es) 2004-04-28
RS50906B (sr) 2010-08-31
HRP20040303B1 (en) 2012-02-29
AR037291A1 (es) 2004-11-03
KR20050044318A (ko) 2005-05-12
DE60220084T2 (de) 2008-01-10
PE20030740A1 (es) 2003-08-28
NZ552129A (en) 2008-04-30
GEP20074097B (en) 2007-05-10
IL161114A (en) 2010-11-30
EA007325B1 (ru) 2006-08-25
MEP1108A (en) 2011-02-10
CY1106765T1 (el) 2012-05-23
ATE361753T1 (de) 2007-06-15
PL369027A1 (en) 2005-04-18
DE60220084D1 (de) 2007-06-21
PL206008B1 (pl) 2010-06-30
BR0212915A (pt) 2004-10-13
ZA200402464B (en) 2005-06-29
DK1446131T3 (da) 2007-09-10
EP1446131A1 (en) 2004-08-18
AU2002351915B2 (en) 2007-11-29
AP2004003014A0 (en) 2004-06-30
IL161114A0 (en) 2004-08-31
SI1446131T1 (sl) 2007-10-31
MA27071A1 (fr) 2004-12-20
ES2287343T3 (es) 2007-12-16
HUP0401462A2 (en) 2006-02-28
JP2005509007A (ja) 2005-04-07
WO2003041722A1 (en) 2003-05-22
CO5580790A2 (es) 2005-11-30
UA80399C2 (en) 2007-09-25

Similar Documents

Publication Publication Date Title
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DE60225431D1 (de) Dialysekatheter
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DE50208638D1 (de) Katheter
NO20033204D0 (no) Terapeutiske kromonforbindelser
DE60212066D1 (de) Abgabespritze
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
IS6954A (is) Notkun á enantíómerískt hreinu essítalóprami
NO20033205D0 (no) Terapeutiske kromanforbindelser
DK1443938T3 (da) Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse
DE50209245D1 (de) Neuroprotektives medikament
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
IS7092A (is) Einfaldur skammtur af asíþrómýsíni til meðhöndlunar á sýkingum í öndunarvegi
DE50303099D1 (de) Patientenlagerungstisch
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
DK1200114T3 (da) PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme
IS7199A (is) Notkun á tilteknum skammti af fondaparínux-natríum til meðhöndlunar á bráðum heilkennum kransæðabilana
IS5996A (is) Notkun á kólesteról lækkandi miðli
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
IS7537A (is) Notkun á nýjum etónógestrel esterum.